The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
-
Eur J Contracept Reprod Health Care · Feb 2019
Hormonal contraception in women with endometriosis: a systematic review.
A systematic review was carried out of studies of women with endometriosis, to examine the evidence for efficacy of the use of hormonal contraception to improve disease-related pain and decrease postoperative risk of disease recurrence. ⋯ CHCs and POCs are effective for the relief of endometriosis-related dysmenorrhoea, pelvic pain and dyspareunia, and improve QoL. Some COCs decreased the risk of disease recurrence after conservative surgery, but POCs did not. There is insufficient evidence, however, to reach definitive conclusions about the overall superiority of any particular hormonal contraceptive.
-
Eur J Contracept Reprod Health Care · Feb 2019
Meta AnalysisContraceptive practices among unmarried women in China, 1982-2017: systematic review and meta-analysis.
Premarital sexual practices and contraceptive prevalence rate (CPR) among unmarried women in China remain unclear. We conducted a systematic review and meta-analysis to estimate CPR and analyse contraceptive methods used by unmarried women between 1982 and 2017. ⋯ The sexual and reproductive health situation of unmarried women in China seems to have improved little since the 1990s. Our findings may help to optimise reproductive health care programmes and thereby reduce the alarming rates of unplanned pregnancies and abortions among unmarried women in China.
-
Eur J Contracept Reprod Health Care · Dec 2018
Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database.
The aim of this study was to evaluate the continuation rates of reimbursed contraceptive methods in French real-world conditions. ⋯ This study conducted in real-world conditions showed that long-acting reversible contraceptive (LARC) methods remain rarely used in France despite high continuation rates over 2 years. Increasing the use of LARC methods is therefore a public health priority.
-
Eur J Contracept Reprod Health Care · Apr 2018
Observational StudyDual method use among long-acting reversible contraceptive users.
To compare rates of dual method use (concurrent use of condoms and an effective method of contraception) in long-acting reversible contraceptive (LARC) and non-LARC hormonal contraceptive users, and to determine factors associated with dual method use. ⋯ Clinicaltrials.gov Identifier NCT01986439.
-
Eur J Contracept Reprod Health Care · Oct 2017
Observational StudyRisk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception vs LNG-IUS.
The study assessed the risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of either a combined oral contraceptive pill (COC) or the levonorgestrel-releasing intrauterine system (LNG-IUS). ⋯ The use of COCs and LNG-IUS is associated with an increased, comparable risk of acquisition of bacterial vaginosis, T. vaginalis and C. albicans infections, which is greatest during initial use of the method but which improves over time.